This report provides an overview of digital innovation in diabetes care, focusing on connected devices, digital applications, and algorithms. It explains how technologies such as CGMs, smart pens, hybrid closed-loop systems, and AI-driven analytics can improve glycemic control, patient engagement, and care efficiency. Evidence suggests benefits across clinical, psychosocial, and economic dimensions, including improved HbA1c, increased time-in-range, and reduced healthcare utilization. However, access remains limited by reimbursement gaps, data fragmentation, usability challenges, and training needs. The report concludes that integrated digital ecosystems and policy alignment are essential for realizing the full value of diabetes technologies.

Join for free to read